Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) Columbia University |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000215 |
The purpose of this study is to evaluate the effects of pergolide on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders |
Drug: Pergolide |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | IV Cocaine Abuse: A Laboratory Model |
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Please contact site for information.
Study ID Numbers: | NIDA-06234-4, R01-06234-4 |
Study First Received: | September 20, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00000215 |
Health Authority: | United States: Federal Government |
Cocaine-Related Disorders Dopamine Mental Disorders Substance-Related Disorders |
Disorders of Environmental Origin Cocaine Pergolide |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs |
Dopamine Agents Dopamine Agonists Pharmacologic Actions |